SenesTech Reports Significant Reductions in Rodent Activity
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 18 2026
0mins
Should l Buy SNES?
SenesTech reported significant reductions in rodent activity following multi-month deployments of Evolve Rat Birth Control in two urban locations. "In the first monitored area, where Evolve placement began in April 2025, tracking plate data collected from August 2025 through January 2026 showed declines in both rodent presence and activity levels. The proportion of plates marked with rodent tracks declined from an average of 74% in August 2025 to 15% in January 2026, representing a 79% reduction in overall plate presence. Track density on plates with rodent presence decreased by 88% over the same period. While baseline data prior to the initial April 2025 product placement were not available, these findings indicate that within five months of monitored observation, rodent activity in the surveyed area declined in both prevalence and intensity," the company stated.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SNES?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SNES
Wall Street analysts forecast SNES stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.470
Low
10.00
Averages
10.00
High
10.00
Current: 1.470
Low
10.00
Averages
10.00
High
10.00
No data
About SNES
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
SenesTech Appoints New CEO to Drive E-Commerce Growth
- Executive Appointment: SenesTech announced that Michael Edell will take over as president and CEO on May 6, 2026, leveraging his extensive experience in e-commerce, sales, and customer growth to drive revenue and improve execution.
- Board Restructuring: The company also appointed Matthew Szot as Board Chair, while Dr. Jamie Bechtel will continue in governance and compensation leadership roles, ensuring strategic alignment and effective oversight.
- E-Commerce Sales Growth: SenesTech plans to expand direct-to-consumer sales through Amazon and its own online platform, with a strong focus on subscription-based recurring revenue to adapt to market trends and enhance customer loyalty.
- Strategic Transformation: This executive transition and the implementation of e-commerce strategies signify SenesTech's proactive approach to market challenges, aiming for accelerated growth and increased market share in 2026.
See More
SenesTech Appoints New CEO to Drive Growth
- Leadership Transition: SenesTech appointed Michael Edell as CEO on May 6, 2026, aiming to leverage his extensive e-commerce and direct-to-consumer expertise to drive commercial growth in the humane pest control market.
- Operational Efficiency: Since mid-2025, Edell has worked closely with SenesTech, and as Interim COO, he streamlined operations and prioritized direct-to-consumer revenue, enhancing the company's market responsiveness.
- Market Expansion Strategy: The new CEO emphasizes focusing resources on high-impact commercial opportunities, particularly on Amazon and the company's e-commerce platform, utilizing data-driven marketing and customer education to drive efficient growth and expand subscription revenue.
- Product Line Expansion Plans: SenesTech plans to introduce additional rodent control products under the Evolve brand to strengthen its competitive position in the underpenetrated pest management market, ensuring sustainable long-term growth.
See More
SenesTech Appoints New CEO to Drive Growth
- Leadership Transition: SenesTech appointed Michael Edell as CEO effective May 6, 2026, aiming to leverage his e-commerce and direct-to-consumer expertise to drive commercial growth and operational execution.
- Operational Efficiency: Since mid-2025, Edell has worked closely with SenesTech to streamline B2B processes and prioritize direct-to-consumer revenue, thereby strengthening the company's commercial infrastructure.
- Market Expansion Strategy: The new CEO emphasizes focusing on e-commerce and direct-to-consumer channels, particularly on Amazon, to drive efficient growth and expand subscription revenue, highlighting the company's commitment to future market opportunities.
- Board Updates: Matthew Szot has been appointed Board Chair as part of the leadership transition, reflecting the company's ongoing focus on operational execution and strong corporate governance to enhance overall market competitiveness.
See More
SenesTech, Inc. Q4 2025 Earnings Call Insights
- CEO Transition Management: Following Joel Fruendt's retirement, SenesTech is conducting a formal search for a new CEO, with management emphasizing that the transition is orderly and business operations continue uninterrupted, ensuring strategic stability and effective resource allocation.
- Significant Revenue Growth: In 2025, SenesTech reported a 20% year-over-year revenue increase to approximately $2.2 million, despite a $200,000 revenue impact in Q4 from the transition to direct Amazon sales, indicating strong market demand overall.
- Successful E-commerce Strategy: E-commerce revenue surged by 88%, now accounting for over half of total revenue, demonstrating the company's robust performance on Amazon and its direct-to-consumer website, which is expected to further drive future growth.
- Legal Dispute Resolution: The legal dispute with Liphatech has been resolved satisfactorily, with all litigation dismissed, and management has committed to maintaining communication with shareholders to ensure business stability during the leadership transition.
See More
SenesTech (SNES) Q4 2025 Earnings Call Transcript
See More
SenesTech Schedules Q4 and FY 2025 Financial Results Release
- Financial Results Announcement: SenesTech is set to release its fourth quarter and fiscal year 2025 financial results after market close on March 12, 2026, reflecting the company's ongoing commitment to financial transparency.
- Conference Call Timing: On the same day, a conference call will be held at 5:00 p.m. ET to analyze the financial results in depth and engage with investors, thereby enhancing investor relations.
- Live Webcast Information: Interested parties can access the conference call via a live webcast available in the Investor Relations section of the company's website, ensuring broad dissemination and transparency of information.
- Replay Availability: A replay of the webcast will be accessible in the Investor Relations section for at least 90 days post-conference, further improving information accessibility and company transparency.
See More
SenesTech Appoints New CEO to Drive E-Commerce Growth
- Executive Appointment: SenesTech announced that Michael Edell will take over as president and CEO on May 6, 2026, leveraging his extensive experience in e-commerce, sales, and customer growth to drive revenue and improve execution.
- Board Restructuring: The company also appointed Matthew Szot as Board Chair, while Dr. Jamie Bechtel will continue in governance and compensation leadership roles, ensuring strategic alignment and effective oversight.
- E-Commerce Sales Growth: SenesTech plans to expand direct-to-consumer sales through Amazon and its own online platform, with a strong focus on subscription-based recurring revenue to adapt to market trends and enhance customer loyalty.
- Strategic Transformation: This executive transition and the implementation of e-commerce strategies signify SenesTech's proactive approach to market challenges, aiming for accelerated growth and increased market share in 2026.
See More
SenesTech Appoints New CEO to Drive Growth
- Leadership Transition: SenesTech appointed Michael Edell as CEO on May 6, 2026, aiming to leverage his extensive e-commerce and direct-to-consumer expertise to drive commercial growth in the humane pest control market.
- Operational Efficiency: Since mid-2025, Edell has worked closely with SenesTech, and as Interim COO, he streamlined operations and prioritized direct-to-consumer revenue, enhancing the company's market responsiveness.
- Market Expansion Strategy: The new CEO emphasizes focusing resources on high-impact commercial opportunities, particularly on Amazon and the company's e-commerce platform, utilizing data-driven marketing and customer education to drive efficient growth and expand subscription revenue.
- Product Line Expansion Plans: SenesTech plans to introduce additional rodent control products under the Evolve brand to strengthen its competitive position in the underpenetrated pest management market, ensuring sustainable long-term growth.
See More
SenesTech Appoints New CEO to Drive Growth
- Leadership Transition: SenesTech appointed Michael Edell as CEO effective May 6, 2026, aiming to leverage his e-commerce and direct-to-consumer expertise to drive commercial growth and operational execution.
- Operational Efficiency: Since mid-2025, Edell has worked closely with SenesTech to streamline B2B processes and prioritize direct-to-consumer revenue, thereby strengthening the company's commercial infrastructure.
- Market Expansion Strategy: The new CEO emphasizes focusing on e-commerce and direct-to-consumer channels, particularly on Amazon, to drive efficient growth and expand subscription revenue, highlighting the company's commitment to future market opportunities.
- Board Updates: Matthew Szot has been appointed Board Chair as part of the leadership transition, reflecting the company's ongoing focus on operational execution and strong corporate governance to enhance overall market competitiveness.
See More
SenesTech, Inc. Q4 2025 Earnings Call Insights
- CEO Transition Management: Following Joel Fruendt's retirement, SenesTech is conducting a formal search for a new CEO, with management emphasizing that the transition is orderly and business operations continue uninterrupted, ensuring strategic stability and effective resource allocation.
- Significant Revenue Growth: In 2025, SenesTech reported a 20% year-over-year revenue increase to approximately $2.2 million, despite a $200,000 revenue impact in Q4 from the transition to direct Amazon sales, indicating strong market demand overall.
- Successful E-commerce Strategy: E-commerce revenue surged by 88%, now accounting for over half of total revenue, demonstrating the company's robust performance on Amazon and its direct-to-consumer website, which is expected to further drive future growth.
- Legal Dispute Resolution: The legal dispute with Liphatech has been resolved satisfactorily, with all litigation dismissed, and management has committed to maintaining communication with shareholders to ensure business stability during the leadership transition.
See More
SenesTech (SNES) Q4 2025 Earnings Call Transcript
See More
SenesTech Schedules Q4 and FY 2025 Financial Results Release
- Financial Results Announcement: SenesTech is set to release its fourth quarter and fiscal year 2025 financial results after market close on March 12, 2026, reflecting the company's ongoing commitment to financial transparency.
- Conference Call Timing: On the same day, a conference call will be held at 5:00 p.m. ET to analyze the financial results in depth and engage with investors, thereby enhancing investor relations.
- Live Webcast Information: Interested parties can access the conference call via a live webcast available in the Investor Relations section of the company's website, ensuring broad dissemination and transparency of information.
- Replay Availability: A replay of the webcast will be accessible in the Investor Relations section for at least 90 days post-conference, further improving information accessibility and company transparency.
See More
